NCT07359404 2026-01-22Sacituzumab Govitecan Plus Bevacizumab in Metastatic TNBCCancer Institute and Hospital, Chinese Academy of Medical SciencesPhase 2 Enrolling by invitation60 enrolled
NCT04524000 2026-01-12Study Assessing the Efficacy and Safety of Treatment With Alpelisib Plus Fulvestrant in Japanese Men and Postmenopausal Women With Advanced Breast CancerNovartisPhase 2 Active not recruiting24 enrolled